Target intelligence / Profile preview

Sex steroid hormone synthesis pathway

Molecular classification
Enzyme, Metabolic pathway, Other
01

Overview

Sex steroid hormone synthesis is the enzymatic process by which cholesterol is converted into biologically active sex steroids: estrogen, androgen, and progestogen hormones. This process involves several key enzymes, including cholesterol side-chain cleavage enzyme (CYP11A1), 17α-hydroxylase/17,20-lyase (CYP17A1), 3β-hydroxysteroid dehydrogenase (HSD3B), 17β-hydroxysteroid dehydrogenase (HSD17B), and aromatase (CYP19). These enzymes catalyze a series of reactions that determine tissue-specific and sex-specific steroid hormone profiles. Many of these enzymes are therapeutic targets in hormone-dependent cancers and endocrine disorders, and their function is essential for sexual differentiation, reproduction, and overall endocrine health[2][4][1]. Drugs targeting these enzymes aim to modulate hormone levels for disease treatment but present significant safety challenges related to the complexity and systemic role of steroid hormones[1][3][4].

Other names
Steroidogenesis pathwaySex steroid biosynthetic pathwaySteroid hormone biosynthetic pathwaySex steroid metabolism pathway
02

Mechanism of action

Inhibition of biosynthetic enzymes to block sex steroid production (e.g., CYP17A1, CYP19 (aromatase)); Competitive antagonism at the active site; Blocking cholesterol side-chain cleavage

03

Biological functions

Biosynthesis of sex steroid hormonesRegulation of reproductive functionModulation of development and differentiationNeuroendocrine signaling (in select tissues)
04

Disease associations

Cancer (prostate, breast, ovarian—hormone-dependent tumors)Endocrine disorders (congenital adrenal hyperplasia, polycystic ovary syndrome)Reproductive disorders (infertility, hormonal imbalance)Other (metabolic syndrome, neuropsychiatric disorders)
05

Safety considerations

Off-target hormonal suppression (risk of adrenal insufficiency, loss of sex hormone function)Endocrine side effects (gynecomastia, infertility, sexual dysfunction)Hepatic toxicity (e.g., with ketoconazole)Risk of bone loss and metabolic disturbances
06

Interacting drugs

Ketoconazole

4 more in the full profile.

07

Biomarkers

Serum levels of testosterone, estradiol, progesteronePrecursors and metabolites (e.g., DHEA, androstenedione, estrone)Enzyme expression levels (e.g., CYP17A1, HSD17B)

Beyond the preview

Go deeper on Sex steroid hormone synthesis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sex steroid hormone synthesis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call